Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6194431A · kind A · utility
4Cited by
6References
21Claims
0Family size
Inventor
Key dates
| Filing date | Apr 14, 1998 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Apr 14, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions employing a terfenadine metabolite and a leukotriene inhibitor for the treatment or prevention of inflammation or allergic disorders, such as asthma, or symptoms thereof. Also included are methods and compositions employing a terfenadine metabolite, a leukotriene inhibitor, and a decongestant for the treatment or prevention of inflammation or allergic disorders, such as asthma, or symptoms thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.